New hair serum shows promise in battle against balding
NCT ID NCT06556056
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study tested a new hair growth serum called SesZen-Bio against a standard treatment (minoxidil 1%) and a placebo in 108 adults with mild to moderate androgenic alopecia (male or female pattern baldness). Participants applied the serum daily to their scalp for several weeks. Researchers measured changes in hair thickness, density, and growth rate using a special imaging device. The goal was to see if the new serum is safe and effective for treating hair loss.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SesZen-Bio Serum (topical) and Minoxidil 1% serum (topical)
What this could lead to
If it works, this could offer a new topical option for people with mild to moderate hair loss, potentially with fewer side effects than standard treatments.
What could go wrong
This is a small, early-stage study (108 people) with no phase designation. Results may not apply to everyone, and the new serum may not outperform existing options like minoxidil.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANDROGENIC ALOPECIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
NovoBliss Research Private Limited
Ahmedabad, Gujarat, 382481, India